Cargando…
P33 EFFECTIVENESS AND SAFETY OF BELANTAMAB MAFODOTIN IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA IN REAL-LIFE SETTING: THE ALFA STUDY
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171737/ http://dx.doi.org/10.1097/01.HS9.0000936260.48784.ae |
| _version_ | 1785039486229413888 |
|---|---|
| author | Roussel, M. Texier, N. Germain, R. Sapra, S. Paka, P. Kerbouche, N. Colin, X. Leleu, X. |
| author_facet | Roussel, M. Texier, N. Germain, R. Sapra, S. Paka, P. Kerbouche, N. Colin, X. Leleu, X. |
| author_sort | Roussel, M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10171737 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101717372023-05-11 P33 EFFECTIVENESS AND SAFETY OF BELANTAMAB MAFODOTIN IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA IN REAL-LIFE SETTING: THE ALFA STUDY Roussel, M. Texier, N. Germain, R. Sapra, S. Paka, P. Kerbouche, N. Colin, X. Leleu, X. Hemasphere Poster Lippincott Williams & Wilkins 2023-05-09 /pmc/articles/PMC10171737/ http://dx.doi.org/10.1097/01.HS9.0000936260.48784.ae Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Poster Roussel, M. Texier, N. Germain, R. Sapra, S. Paka, P. Kerbouche, N. Colin, X. Leleu, X. P33 EFFECTIVENESS AND SAFETY OF BELANTAMAB MAFODOTIN IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA IN REAL-LIFE SETTING: THE ALFA STUDY |
| title | P33 EFFECTIVENESS AND SAFETY OF BELANTAMAB MAFODOTIN IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA IN REAL-LIFE SETTING: THE ALFA STUDY |
| title_full | P33 EFFECTIVENESS AND SAFETY OF BELANTAMAB MAFODOTIN IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA IN REAL-LIFE SETTING: THE ALFA STUDY |
| title_fullStr | P33 EFFECTIVENESS AND SAFETY OF BELANTAMAB MAFODOTIN IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA IN REAL-LIFE SETTING: THE ALFA STUDY |
| title_full_unstemmed | P33 EFFECTIVENESS AND SAFETY OF BELANTAMAB MAFODOTIN IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA IN REAL-LIFE SETTING: THE ALFA STUDY |
| title_short | P33 EFFECTIVENESS AND SAFETY OF BELANTAMAB MAFODOTIN IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA IN REAL-LIFE SETTING: THE ALFA STUDY |
| title_sort | p33 effectiveness and safety of belantamab mafodotin in patients with relapsed/refractory multiple myeloma in real-life setting: the alfa study |
| topic | Poster |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171737/ http://dx.doi.org/10.1097/01.HS9.0000936260.48784.ae |
| work_keys_str_mv | AT rousselm p33effectivenessandsafetyofbelantamabmafodotininpatientswithrelapsedrefractorymultiplemyelomainreallifesettingthealfastudy AT texiern p33effectivenessandsafetyofbelantamabmafodotininpatientswithrelapsedrefractorymultiplemyelomainreallifesettingthealfastudy AT germainr p33effectivenessandsafetyofbelantamabmafodotininpatientswithrelapsedrefractorymultiplemyelomainreallifesettingthealfastudy AT sapras p33effectivenessandsafetyofbelantamabmafodotininpatientswithrelapsedrefractorymultiplemyelomainreallifesettingthealfastudy AT pakap p33effectivenessandsafetyofbelantamabmafodotininpatientswithrelapsedrefractorymultiplemyelomainreallifesettingthealfastudy AT kerbouchen p33effectivenessandsafetyofbelantamabmafodotininpatientswithrelapsedrefractorymultiplemyelomainreallifesettingthealfastudy AT colinx p33effectivenessandsafetyofbelantamabmafodotininpatientswithrelapsedrefractorymultiplemyelomainreallifesettingthealfastudy AT leleux p33effectivenessandsafetyofbelantamabmafodotininpatientswithrelapsedrefractorymultiplemyelomainreallifesettingthealfastudy |